Literature DB >> 20659426

Involvement of AMP-activated-protein-kinase (AMPK) in neuronal amyloidogenesis.

Je-Seong Won1, Yeong-Bin Im, Jinsu Kim, Avtar K Singh, Inderjit Singh.   

Abstract

AMP-activated-protein-kinase (AMPK) is a key sensor and regulator of cellular and whole-body energy metabolism and plays a key role in regulation of lipid metabolism. Since lipid metabolism has been implicated in neuronal amyloid-beta (Abeta) homeostasis and onset of Alzheimer's disease, we investigated the involvement of AMPK in neuronal lipid metabolism and Abeta production. We observed in cultured rat cortical neurons that Abeta production was significantly reduced when the neurons were stimulated with AMPK activator, 5-aminoimidazole-4-carboxamide-1-d-ribofuranoside (AICAR), but increased when AMPKalpha2 was knocked out, thus indicating the role of AMPK in amyloidogenesis. Although the detailed mechanisms by which AMPK regulates Abeta generation is not well understood, AMPK-mediated alterations in cholesterol and sphingomyelin homeostasis and in turn the altered distribution of Abeta precursor-protein (APP) in cholesterol and sphingomyelin rich membrane lipid rafts participate in Abeta generation. Taken together, this is the first report on the role of AMPK in regulation of neuronal amyloidogenesis. Copyright 2010. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20659426      PMCID: PMC2977999          DOI: 10.1016/j.bbrc.2010.07.081

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

Review 1.  AMP-activated protein kinase as a drug target.

Authors:  D Grahame Hardie
Journal:  Annu Rev Pharmacol Toxicol       Date:  2007       Impact factor: 13.820

2.  The AMP-activated protein kinase prevents ceramide synthesis de novo and apoptosis in astrocytes.

Authors:  C Blázquez; M J Geelen; G Velasco; M Guzmán
Journal:  FEBS Lett       Date:  2001-02-02       Impact factor: 4.124

3.  Prevalence of overweight and obesity in the United States, 1999-2004.

Authors:  Cynthia L Ogden; Margaret D Carroll; Lester R Curtin; Margaret A McDowell; Carolyn J Tabak; Katherine M Flegal
Journal:  JAMA       Date:  2006-04-05       Impact factor: 56.272

Review 4.  AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy.

Authors:  D Grahame Hardie
Journal:  Nat Rev Mol Cell Biol       Date:  2007-10       Impact factor: 94.444

5.  Characterisation of 5'-AMP-activated protein kinase in human liver using specific peptide substrates and the effects of 5'-AMP analogues on enzyme activity.

Authors:  J E Sullivan; F Carey; D Carling; R K Beri
Journal:  Biochem Biophys Res Commun       Date:  1994-05-16       Impact factor: 3.575

6.  Statin inhibits kainic acid-induced seizure and associated inflammation and hippocampal cell death.

Authors:  Jin-Koo Lee; Je-Seong Won; Avtar K Singh; Inderjit Singh
Journal:  Neurosci Lett       Date:  2008-06-06       Impact factor: 3.046

7.  The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity.

Authors:  Benoit Viollet; Fabrizio Andreelli; Sebastian B Jørgensen; Christophe Perrin; Alain Geloen; Daisy Flamez; James Mu; Claudia Lenzner; Olivier Baud; Myriam Bennoun; Emmanuel Gomas; Gaël Nicolas; Jørgen F P Wojtaszewski; Axel Kahn; David Carling; Frans C Schuit; Morris J Birnbaum; Erik A Richter; Rémy Burcelin; Sophie Vaulont
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

8.  AMPK inhibitor Compound C stimulates ceramide production and promotes Bax redistribution and apoptosis in MCF7 breast carcinoma cells.

Authors:  Junfei Jin; Thomas D Mullen; Qi Hou; Jacek Bielawski; Alicja Bielawska; Xiaoming Zhang; Lina M Obeid; Yusuf A Hannun; Yi-Te Hsu
Journal:  J Lipid Res       Date:  2009-06-15       Impact factor: 5.922

9.  AMP-activated protein kinase is highly expressed in neurons in the developing rat brain and promotes neuronal survival following glucose deprivation.

Authors:  C Culmsee; J Monnig; B E Kemp; M P Mattson
Journal:  J Mol Neurosci       Date:  2001-08       Impact factor: 2.866

10.  AICAR inhibits adipocyte differentiation in 3T3L1 and restores metabolic alterations in diet-induced obesity mice model.

Authors:  Shailendra Giri; Ramandeep Rattan; Ehtishamul Haq; Mushfiquddin Khan; Rifat Yasmin; Je-song Won; Lyndon Key; Avtar K Singh; Inderjit Singh
Journal:  Nutr Metab (Lond)       Date:  2006-08-10       Impact factor: 4.169

View more
  31 in total

Review 1.  Energy dysfunction in Huntington's disease: insights from PGC-1α, AMPK, and CKB.

Authors:  Tz-Chuen Ju; Yow-Sien Lin; Yijuang Chern
Journal:  Cell Mol Life Sci       Date:  2012-05-25       Impact factor: 9.261

Review 2.  Bioenergy sensing in the brain: the role of AMP-activated protein kinase in neuronal metabolism, development and neurological diseases.

Authors:  Stephen Amato; Heng-Ye Man
Journal:  Cell Cycle       Date:  2011-10-15       Impact factor: 4.534

Review 3.  Therapeutic Potential of AMP-Activated Protein Kinase in Alzheimer's Disease.

Authors:  Xin Wang; Helena R Zimmermann; Tao Ma
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 4.  Roles of AMP-activated protein kinase in Alzheimer's disease.

Authors:  Zhiyou Cai; Liang-Jun Yan; Keshen Li; Sohel H Quazi; Bin Zhao
Journal:  Neuromolecular Med       Date:  2012-02-26       Impact factor: 3.843

5.  Autophagy in microglia degrades extracellular β-amyloid fibrils and regulates the NLRP3 inflammasome.

Authors:  Mi-Hyang Cho; Kwangmin Cho; Hoe-Jin Kang; Eun-Young Jeon; Hun-Sik Kim; Hyung-Joon Kwon; Hong-Mi Kim; Dong-Hou Kim; Seung-Yong Yoon
Journal:  Autophagy       Date:  2014-07-22       Impact factor: 16.016

Review 6.  Small molecule adenosine 5'-monophosphate activated protein kinase (AMPK) modulators and human diseases.

Authors:  Sandeep Rana; Elizabeth C Blowers; Amarnath Natarajan
Journal:  J Med Chem       Date:  2014-08-28       Impact factor: 7.446

Review 7.  Research Progress on Alzheimer's Disease and Resveratrol.

Authors:  Yan Yan; Huihuang Yang; Yuxun Xie; Yuanlin Ding; Danli Kong; Haibing Yu
Journal:  Neurochem Res       Date:  2020-03-11       Impact factor: 3.996

8.  Decreased Levels of Blood AMPKα1 but not AMPKα2 Isoform in Patients with Mild Cognitive Impairment and Alzheimer's Disease: A Pilot Study.

Authors:  Xin Wang; Helena R Zimmermann; Samuel N Lockhart; Suzanne Craft; Tao Ma
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

9.  Clozapine Improves Memory Impairment and Reduces Aβ Level in the Tg-APPswe/PS1dE9 Mouse Model of Alzheimer's Disease.

Authors:  Yura Choi; Ha Jin Jeong; Quan Feng Liu; Seung Tack Oh; Byung-Soo Koo; Yeni Kim; In-Won Chung; Yong Sik Kim; Songhee Jeon
Journal:  Mol Neurobiol       Date:  2016-01-07       Impact factor: 5.590

10.  Adenosine monophosphate-activated protein kinase overactivation leads to accumulation of α-synuclein oligomers and decrease of neurites.

Authors:  Peizhou Jiang; Ming Gan; Abdul Shukkur Ebrahim; Monica Castanedes-Casey; Dennis W Dickson; Shu-Hui C Yen
Journal:  Neurobiol Aging       Date:  2012-11-28       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.